J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' biggest wheelers ...

Clear Labs, a San Carlos sequencing company for diagnostics, raised a $30 million in Series D funding, Axios reports.

Sage Therapeutics reported that Biogen made an unsolicited offer to purchase all of the shares of the biopharmaceutical firm it doesn't already own.

Shares of Moderna tumbled Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year.

Following last month’s fatal shooting of an insurance executive, healthcare’s largest investor meeting has assumed a higher ...

Reports $709 million in preliminary1 full-year 2024 U.S. net product revenues$611 million in SYFOVRE® U.S. net product revenues, including $167 ...

J&J agreed to buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of reentry into neuroscience by large ...

Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year.  | For ...

The annual conference features presentations from more than 500 private and public companies. Follow here for live coverage.

San Francisco and its hotel industry are partnering to beef up security around this week's 43rd annual J.P. Morgan Healthcare ...

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar depression.

The biopharma industry’s deal-a-palooza, better known as the J.P. Morgan Healthcare Conference, has kicked off in San ...